Evidence map›Paper›PMID 28731570›Full record

ArticleJournal of magnetic resonance imaging : JMRI2018

Susceptibility weighted imaging and quantitative susceptibility mapping of the cerebral vasculature using ferumoxytol.

Saifeng Liu, Jean-Christophe Brisset, Jiani Hu, E Mark Haacke, Yulin Ge

Open access · greenAbstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Advancements in MRI application in the morphological development of fetal cerebral venous system: a review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Black-Blood Contrast in Cardiovascular MRI.Journal of magnetic resonance imaging : JMRI · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Saifeng LiuThe MRI Institute for Biomedical Research, Detroit, Michigan, USA.
Jean-Christophe BrissetCenter for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, New York, USA.
Jiani HuDepartment of Radiology, Wayne State University, Detroit, Michigan, USA.
E Mark HaackeThe MRI Institute for Biomedical Research, Detroit, Michigan, USA.
Yulin GeCenter for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, New York, USA.
Magnetic Resonance Imaging Institute for Biomedical Research · USNew York University · USWayne State University · US

Funding

TR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical careP41EB017183 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Hersh Chandarana · 2014 to 2026
$19.3M
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple SclerosisR01NS076588 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GE, YULIN · 2012 to 2016
$2.7M
(PQC5 in RFA-CA-12-020) Using MR phase to detect ferritin tagged breast cancer ceR21CA184682 · NCI · WAYNE STATE UNIVERSITY · PI HU, JIANI, WANG, JIANJUN · 2014 to 2015
$364k
NCI NIH HHS R21 CA184682NIBIB NIH HHS P41 EB017183NINDS NIH HHS R01 NS076588
6 · The paper itself

Abstract

purposeTo demonstrate the potential of imaging cerebral arteries and veins with ferumoxytol using susceptibility weighted imaging (SWI) and quantitative susceptibility mapping (QSM). MATERIALS AND

methodsThe relationships between ferumoxytol concentration and the apparent susceptibility at 1.5T, 3T, and 7T were determined using phantom data; the ability of visualizing subvoxel vessels was evaluated using simulations; and the feasibility of using ferumoxytol to enhance the visibility of small vessels was confirmed in three healthy volunteers at 7T(with doses 1 mg/kg to 4 mg/kg). The visualization of the lenticulostriate arteries and the medullary veins was assessed by two raters and the contrast-to-noise ratios (CNRs) of these vessels were measured.

resultsThe relationship between ferumoxytol concentration and susceptibility was linear with a slope 13.3 ± 0.2 ppm·mg

conclusionThe CNR for cerebral vessels with ferumoxytol can be enhanced using SWI, and the apparent susceptibilities of the arteries can be reliably quantified using QSM. This approach improves the imaging of the entire vascular system outside the capillaries and may be valuable for a variety of neurodegenerative diseases which involve the microvasculature. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:621-633.

Indexed as

Ferrosoferric OxideAdultBrainCerebral ArteriesFemaleHumansImage EnhancementImage Processing, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance ImagingMiddle AgedPhantoms, ImagingReference ValuesFerrosoferric Oxideferumoxytolimaging cerebral vasculaturequantitative susceptibility mapping (QSM)susceptibility weighted imaging (SWI)ultra-small superparamagnetic iron oxide (USPIO)

Identifiers

PMID28731570
PMCPMC5776072
OpenAlexW2737176964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.